Present Status and New Perspectives in Non-Steroidal Anti-Inflammatory Drugs Therapy

References

• Abramson H., Edelson H., Kaplan H., Given W., Weissman G. The neutrophil in rheumatoid arthritis: Its role and the inhibition of its activation by nonsteroidal antiinflammatory drugs. Seminars Arthritis Rheum. 1983; 13: 148, Supp. 1
   PubMedGoogle Scholar
• Abramson S., Edelson M., et al. Inhibition of neutrophil activation by NSAID. Am. J. Med. 1984; 10: 3
   Google Scholar
• Annefeld M. A new test method for the standardized of changes in the ultrastructura of chondrocytes. VII. Int. J. Tiss. Reac. 1985; 4: 273
   Google Scholar
• Baker P. E., Fahey J. V., Munck A. Prostaglandin inhibition of T-cell proliferation is mediated at two levels. Cell Immunol. 1981; 61: 52
   PubMed Web of Science ®Google Scholar
• Bellamy N. Variance in NSAID studies: Contribution of patient variance. Non steroidal antiinflammatory drugs. Birkhauser Verlag, Basel 1985; 21
   Google Scholar
• Borgeat P., Hamberg M., Samuelsson B. Transformation of arachidonic acid and di-homolinoleic acid by PMN. J. Biol. Chem. 1976; 251: 7816
   PubMed Web of Science ®Google Scholar
• Brunda R. J., Heberman R. B., Holden H. T. Inhibition of murine natural killer cell activity by prostaglandins. J. Immunol. 1980; 124: 2682
   PubMed Web of Science ®Google Scholar
• Brune K. Pharmacokinetic factors as causes of variability in response to non steroidal anti-inflammatory drugs. Non steroidal anti-inflammatory drugs. Birkhauser Verlag, Basel 1985; 59
   Google Scholar
• Ciabattoni G., Cinotti C. A., Pierucci A. Effect of sulindac and ibuprofen in patients with chronic glomerular disease. N. Engl. J. Med. 1984; 310: 279
   PubMed Web of Science ®Google Scholar
• Cueppens J. L., Rodriguez M., Goodwin J. S. NSAID inhibit the synthesis of IgM RF in vitro. Lancet 1982; 1: 528
   PubMedGoogle Scholar
• Day R., Graham C., Champion G. D., Lee E. Antirheumatic drug interactions. Clin. Rheum. Dis. 1984; 10: 251
   PubMedGoogle Scholar
• Day R. O. Variability in response to NSAID. Non steroidal antiinflammatory drugs. Birkhauser Verlag, Basel 1985
   Google Scholar
• Ferreira S. H., Vane J. R. Prostaglandins: their disappearance from and release into circulation. Nature 1967; 216: 863
   Google Scholar
• Fontana A., Hengartner H., Weber E., Fehr K., Crob P. J. Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int. 1982; 2: 49
   PubMed Web of Science ®Google Scholar
• Coodwin J. S., Messner R. P., Peake C. T. Prosteglandin suppression of mitogen-stimulated lymphocytes in vitro. J. Clin. Invest. 1978; 62: 753
   PubMedGoogle Scholar
• Coodwin J. S., Bankhurst A. D., Messner R. P. Suppression of human T-cell mitogenesis by prostaglandin. J. Exp. Med. 1977; 142: 1719
   Google Scholar
• Goodwin J. S., Ceuppens L. Effect of nonsteroidal antiinflammatory drugs on immune function—Seminars. Arthritis and Rheumatism 1983; 13: 132, (Suppl.)
   Google Scholar
• Cordon D., Bray M., Morle J. Control of lymphokine secretion by prostaglandins. Nature 1976; 262: 401
   PubMedGoogle Scholar
• Gottlieb N. L. The art and science of nonsteroidal anti-inflammatory drug selection. Seminars. Arthritis and Rheumatism 1985; 15: 1
   Google Scholar
• Hamberg M., Svensson J., Samuelsson B. Tromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Nat. Acad. Sci. 1975; 72
   Google Scholar
• Hanson D. F., Murphy P. A., Siciliano R. n. B. H. S. The effect of temperature on the activation of lymphocytes by interleukin I and II. J. Immunol. 1983; 130: 216
   PubMedGoogle Scholar
• Herman J. H., Appel A. M., Khosla K. C. NSAID effect on chondrocyte anabolic function. Arthritis Rheum. 1984; 27: 577
   Google Scholar
• Jampel H. D., Duff C. W., Gershon R. K., Athins E., Durum S. K. Fever and immunoregulation. HI. Hyperthermia augments the primary in vitro humoral response. J. Exp. Med. 1983; 157: 1229
   PubMed Web of Science ®Google Scholar
• Kaplan H. B., Edelson H. S., Korchak H. M., Given W. P., Abramsonn B. Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo. Biochem. Pharmacol. 1984; 33: 371
   PubMed Web of Science ®Google Scholar
• Krane S. M., Goldring S. R., Dayer J. M. Interactions among lymphocytes, monocytes and other synovial cells in the rheumatoid synovium. New Academic Press 1982; 7: 75
   Google Scholar
• Lifschitz M. Renal effects of non-steroidal anti-inflammatory agents. Agent and Action 1983; 102: 313
   Google Scholar
• Lipsky P. E., Thromphson P. A., Rosenwasser L. J. The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin secreting cells by an antibody against human leukocytic pyrogen. J. Immunol. 1983; 130: 2708
   PubMedGoogle Scholar
• Meffin P. G. The effect of renal dysfunction on the disposition of non-steroidal anti-inflammatory drugs forming acyl-glucoronides. Non steroidal anti-inflammatory drugs. Birkhauser Verlag, Basel 1982
   Google Scholar
• Mizel S. B. Interleukin 1 and T cell activation. Immunol. Rev. 1928; 63: 51
   Google Scholar
• Moncada S., Vane J. R. Pharmacology and endogenous roles of prostaglandin, endoperoxides, tromboxane A2 and prostacyclin. Pharmacol. Rev. 1979; 30: 293
   Web of Science ®Google Scholar
• Morris H. R., Taylor G. W., Piper P. J., Samhoun M. N. Slow reacting substances: the structure identification of SRS from rat basophil leukemia (RBL-1) cells—Prostaglandins
   Google Scholar
• Orme M.L.E. The relationship between the plasma concentration of non steroidal anti-inflammatory drugs and their therapeutic effects. Non steroidal anti-inflammatory drugs. Birkhauser Verlag, Basel 1985; 151
   Google Scholar
• Palrnosky M. J., Brandt K. D. Effects of some nonsteroidal antiinflammatory drugs on prosteoglycan metabolism and organization in camine articular cartilage. Arthr. Rheum. 1980; 23: 1010
   PubMedGoogle Scholar
• Rappaport R. S., Dodge G. R. Prostaglandin E inhibits the production of human interleukin 2. J. Exp. Med. 1982; 155: 943
   PubMed Web of Science ®Google Scholar
• Svendsen D. C., Cerstoft J., Hansen T. M. The renal excretion of prostaglandins and changes in plasma renin during treatment with either Sulindac or Naproxene in patients with Rheumatoid Arthritis and thiaride treated heart failure. J. Rheumatol. 1984; 11: 779
   PubMedGoogle Scholar
• Webb D. Z., Osheroff P. L. Antigen stimulation of prostaglandin synthesis and control of immune responses. Proc. Natl. Acad. Sci USA 1976; 73: 1300
   PubMed Web of Science ®Google Scholar
• Weissmann C. Pathways of arachidonate oxidabiontion to prostaglandins and leukotrienes. Seminars. Arthritis and Rheumatism 1983; 13, Supp. 1
   Google Scholar
• Williams K. M. n. D. R. O. Stereoselective disposition—Basis for variability in response to NSAID'S. Non steroidal antiinflammatory drugs. Birkhauser Verlag, Basel 1985; 119
   Google Scholar